Austar Lifesciences Past Earnings Performance

Past criteria checks 1/6

Austar Lifesciences's earnings have been declining at an average annual rate of -19.3%, while the Life Sciences industry saw earnings growing at 5.6% annually. Revenues have been growing at an average rate of 7% per year. Austar Lifesciences's return on equity is 1.7%, and it has net margins of 1.1%.

Key information

-19.3%

Earnings growth rate

-19.3%

EPS growth rate

Life Sciences Industry Growth	21.5%
Revenue growth rate	7.0%
Return on equity	1.7%
Net Margin	1.1%
Last Earnings Update	31 Dec 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Austar Lifesciences makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

OTCPK:AULS.F Revenue, expenses and earnings (CNY Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
31 Dec 24	1,500	16	239	54
30 Sep 24	1,523	-2	253	52
30 Jun 24	1,545	-19	268	51
31 Mar 24	1,654	-26	301	53
31 Dec 23	1,764	-33	333	55
30 Jun 23	1,972	51	329	64
31 Mar 23	2,065	78	316	67
31 Dec 22	2,157	104	303	70
30 Sep 22	2,246	96	307	71
30 Jun 22	2,264	105	304	72
31 Mar 22	2,139	191	304	69
31 Dec 21	2,015	277	304	66
30 Sep 21	1,824	258	304	59
30 Jun 21	1,633	238	304	52
31 Mar 21	1,465	136	281	50
31 Dec 20	1,296	33	259	48
30 Sep 20	1,193	25	253	47
30 Jun 20	1,089	17	246	45
31 Mar 20	1,069	12	248	44
31 Dec 19	1,049	8	251	43
30 Sep 19	1,007	8	234	39
30 Jun 19	966	8	216	36
31 Mar 19	891	4	200	33
31 Dec 18	817	0	183	30
30 Sep 18	724	-16	182	29
30 Jun 18	631	-33	182	28
31 Mar 18	589	-43	177	27
31 Dec 17	547	-54	171	26
30 Sep 17	587	-43	160	27
30 Jun 17	628	-32	149	28
31 Mar 17	650	-25	150	30
31 Dec 16	673	-19	151	32
30 Sep 16	648	-17	146	32
30 Jun 16	624	-16	141	31
31 Mar 16	626	-5	134	29
31 Dec 15	628	6	127	27
30 Sep 15	640	24	122	26
30 Jun 15	652	43	118	26
31 Mar 15	666	54	120	25
31 Dec 14	680	65	122	24
30 Sep 14	676	58	128	24
30 Jun 14	672	51	133	24

Quality Earnings: AULS.F has a large one-off gain of CN¥4.5M impacting its last 12 months of financial results to 31st December, 2024.

Growing Profit Margin: AULS.F became profitable in the past.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: AULS.F's earnings have declined by 19.3% per year over the past 5 years.

Accelerating Growth: AULS.F has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: AULS.F has become profitable in the last year, making it difficult to compare its past year earnings growth to the Life Sciences industry (-1.7%).

Return on Equity

High ROE: AULS.F's Return on Equity (1.7%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/08 00:05
End of Day Share Price	2025/02/19 00:00
Earnings	2024/12/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Austar Lifesciences Limited is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Milo Liu	BOCOM International Securities Limited
Forrest Chan	CCB International Securities Limited
Tsz Man Chan	KGI Securities Co. Ltd.